AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
The introduction of prostatic artery embolization (PAE) in the American Urological Association guidelines has sparked excitement. PAE is increasingly viewed as a feasible alternative to surgical therapies, and its inclusion in the guidelines reflects its growing recognition. The guidelines emphasize the importance of collaboration between urologists and interventional radiologists, highlighting the need for specialized interventional radiologists with expertise in PAE. Many patients are self-referred, with a significant number seeking PAE after extensive research and not being informed about it by their urologist. The guidelines are expected to lead to increased awareness and adoption of PAE, benefitting patients who prefer minimally invasive options. PAE offers advantages such as preservation of sexual function, out-patient procedures, and low risk profiles for suitable candidates. Insurance coverage and appeals are expected to improve, removing the perception that PAE is experimental. The guidelines may also impact primary care physicians who manage the silent sufferers - men who avoid urologists due to fear of invasive treatments. PAE being included in the guidelines will likely prompt more primary care physicians to consider it as a non-invasive treatment option for lower urinary tract symptoms caused by BPH. Overall, the guidelines provide a boost to PAE and have the potential to increase patient access and improve outcomes.